{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-085198","form_type":"8-K","ticker":"NWBO","cik":"0001072379","company_name":"NORTHWEST BIOTHERAPEUTICS INC","filed_at":"2024-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.098118+00:00","generated_at":"2026-05-31T13:21:52.315722+00:00","sec_items":["7.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"medium","headline":"NW Bio investigates social media rumors; MHRA MAA review continues","bullets":["Company probing rumors linked to parties in federal NY lawsuit; coinciding with stock market developments.","Plans to pursue appropriate action against rumor sources; shareholders asked to report information.","MHRA review of Marketing Authorization Application in UK ongoing; inspections scheduled in US and UK.","CEO Linda Powers signed the disclosure; no financial guidance or earnings data provided."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-085198","json":"https://secwatch.observer/filing/0001104659-24-085198.json","markdown":"https://secwatch.observer/filing/0001104659-24-085198.md","text":"https://secwatch.observer/filing/0001104659-24-085198.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1072379/000110465924085198/0001104659-24-085198-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1072379/000110465924085198/tm2420750d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:21:52.315722+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}